The role focuses on evaluating and executing direct late-stage growth equity investment opportunities primarily in technology and healthcare.
Base: $125,000-$175,000; Bonus/Equity: Discretionary bonus eligible; Benefits: Medical/dental/vision, retirement, life insurance
Must-have
Nice-to-have
Must be authorized to work in the United States